PostEra
PostEra, based in Boston, MA, leverages machine learning to enhance medicinal chemistry, focusing on drug discovery and delivery within the healthcare industry.
Company Overview
PostEra is a healthcare company located in Boston, MA. The firm operates within the drug discovery and delivery sub-industry, leveraging advances in machine learning to streamline medicinal chemistry and accelerate the development of new cures. PostEra partners with biopharma companies to advance small molecule programs and also works on its internal pipeline. With a dedicated team of 34 employees, PostEra is backed by the Y-Combinator W20 batch.
Services
PostEra offers a variety of services designed to enhance the drug discovery and delivery process. Key among these is its software platform, Manifold, which is used for synthesis and search. The company utilizes machine learning to accelerate medicinal chemistry, providing innovative solutions to the healthcare industry. PostEra collaborates with biopharma partners to advance small molecule programs and also focuses on its internal projects.
Major Partnerships
PostEra has established significant partnerships with industry leaders such as Amgen, Pfizer, and the NIH. These collaborations have led to multi-year agreements valued at $1 billion. These partnerships aim to harness the power of artificial intelligence for drug discovery and delivery, further accelerating the development of new therapeutic solutions.
COVID Moonshot Initiative
PostEra launched and led the COVID Moonshot initiative, the world's largest open-science drug discovery effort. This initiative aimed to expedite the discovery of potential antiviral drugs for COVID-19. By utilizing an open-science model, COVID Moonshot brought together global scientists to collaborate and share data, accelerating the discovery process.
Funding
PostEra has successfully raised $26 million from top-tier investors. This funding supports the company's mission to use machine learning for advancing medicinal chemistry and bringing new cures to patients. The financial backing underscores investor confidence in PostEra's innovative approach and potential for impact in the healthcare industry.